15 ms·
Brain imaging before and after Covid-19 in UK Biobank
- wombatmobile 5y agoThis sounds alarming: > There is strong evidence for brain-related pathologies in COVID-19, some of which could be a consequence of viral neurotropism. This doesn't: > We further compared COVID-19 patients who had been hospitalised (n=15) with those who had not (n=379), and while results were not significant, we found comparatively similar findings to the COVID-19 vs control group comparison What are the quantitative findings of "loss of grey matter"? What mechanism/s are suspected that might be specific to COVID19?
- dasudasu 5y ago>Our findings thus consistently relate to loss of grey matter in limbic cortical areas directly linked to the primary olfactory and gustatory system. Looks like the loss of smell is due to an impact of the virus on brain tissue. It would be interesting to check if it ever comes back to normal months/years later.
- ljf 5y agoTotally anecdotal, but my wife who was very ill with both covid and then long covid, only lost her smell for a day before it returned. Another friend who had very few symptoms still has no sense of smell 9 months later - her smell can come and go, and she will also now 'miss-smell' smelling nice things as horrible and horrible as nice.
- goodoldneon 5y agoKind of a tangent, but I get frustrated when researchers publicly release results when one of their groups have a ridiculously small sample size. It’s irresponsible to release results based on 15 people
- deleted 5y ago[deleted]
- Xylakant 5y agoThe article is “published” on a preprint server and carries a suitable warning at the top. It’s preliminary, unverified and not reviewed. The target audience is other researchers, not the general public. It’s useful to publish preliminary results based on low sample sizes, it can guide future research. Basically a “hey, we found something we consider interesting, it may be worth having a better look at this.” It’s very dangerous to read too much into this, though - hence the warning at the top.
- onlyrealcuzzo 5y agoI thought this also - but as it turns out - you can make conclusions with really small sample sizes in medicine. For example (this has nothing to do with the paper), if the average rate of some condition - some rare brain tumor - is 1 in 50M - and you take 200 COVID-19 patients and 4 of them have it - and they have several of these tumors - you can have high CI & Power with a low sample size. When you're doing conversion rate optimization - it's usually just "did this person make a purchase?" And usually, your base rate is not less than 1/1000... But in medicine, there are ways to measure the severity of the symptoms and a lot of things are quite rare.
- buildbot 5y agoThey had over 700 people total, 50% control and 50% infected; which they break down earlier in the same paragraph. The 15 people are those who are hospitalized and the abstract literally says the results from that small group aren’t significant.
- skylanh 5y ago> Here, we studied the effects of the disease in the brain using multimodal data from 782 participants from the UK Biobank COVID-19 re-imaging study, with 394 participants having tested positive for SARSCoV-2 infection between their two scans. 782 participants, 394 of which had positive tests for COVID-19, a further 15 of the 394 were hospitalized due to their symptoms. The interpretation could be: - lung symptoms are not correlated with brain changes - mild infections not requiring hospitalization showed similar pathology to severe infections > What are the quantitative findings of "loss of grey matter"? Page 18 shows the measurements. > What mechanism/s are suspected that might be specific to COVID19? Page 3. > one hypothesis is that an entry point of the virus to the central nervous system might be achieved by crossing the neural–mucosal interface in the olfactory mucosa, and progress from there onto the olfactory bulb in the brain [Meinhardt J, Radke J, Dittmayer C, et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci 2021; 24(2): 168-75.]
- bingbong70 5y ago"Wellcome" sounds familiar. Related to the organization that faked "doubleblind" studies to get AZT approved by the FDA in the 1980s?
- JohnJamesRambo 5y agoI wish I could get people that are avoiding the COVID vaccine “because we don’t know what the long term effects are” to realize that we have real data showing that there are long term effects from getting full blown COVID. You don’t want a tiny piece of mRNA but you want the whole organism reproducing in your body? The whole genome and all the proteins made?
- hallway_monitor 5y agoAgree completely. That said, ideally I don't want either. Since a lot of people wanted to get vaccinated immediately, I can avoid that and the virus with very high probability. If needed, I'll take v3 or so of the mRNA vaccine.
- egeozcan 5y agoIf many people do what you are doing, some percentage can get the virus and allow it to mutate further, reducing the vaccine efficiency, putting others to risk. Prisoner's dilemma at play. meta edit: I don't like your post becoming completely gray and therefore up-voted you. It's a view that many people hold and it needs to be answered not by screaming "down-vote the selfish!" but rather with good arguments.
- hallway_monitor 5y agoOh 100%. It's a selfish play I admit. But if there's greater than zero risk of any long-term unknown effects from a vaccine, the number of people already vaccinated means the expected value is probably negative for anyone who hasn't been vaccinated yet.
- tux3 5y agoIgnoring the blatant disregard for the safety of others, your calculations are off the mark. The Delta variant is the only one you should be concerned about from here on. And a single dose of vaccine only provides minimal protection against it. For your scheme to be safe, you would need about 80% of people around you to have 2+ doses of a high-efficacy vaccine, and ideally all with Pfizer over Astra, given their relative efficacy. There's a greater than zero risk you're going about this wrong and will end up catching a new variant. Vaccination works, if you ACTUALLY GET THE SHOTS. Cheers
- elboulangero 5y agoFWIW this thread was a good read: https://mobile.twitter.com/skepticalzebra/status/1405899724117393411 https://mobile.twitter.com/skepticalzebra/status/14058997241... Apparently there are previous studies (pre-covid Era) that found similar changes in the brain associated with loss of smell. Quoting: > What if I told you there was also an illness in which: > "grey matter reduction was observed in the gyrus rectus, orbitofrontal cortex, thalamus, and the insula" > This is taken from a study on Chronic rhinosinusitis with olfactory loss
- ganzuul 5y agoCall me stupid for waiting to get vaccinated... But I'm not stupid enough to base that decision on a Twitter thread. The problem I have is that inclusive discussion is being suppressed, and I can't make a decision based on clearly biased information. ref. https://www.youtube.com/watch?v=-_NNTVJzqtY https://www.youtube.com/watch?v=-_NNTVJzqtY
- TaupeRanger 5y agoThe video you linked is removed.for violating guidelines, which I'm guessing means it had a conspiratorial slant. Discussion does not have to include unsupported or crackpot claims to be "inclusive".
- username90 5y agoI am pro vaccine, but youtube moderators are not subject matter experts, they are unskilled volunteers with very simple guidelines such as (made up rule by me, I don't fully know): "remove any video discouraging people from getting vaccinated". Therefore youtube removing a specific video doesn't say anything about the quality of its content, just that some random guy thought it violated the guidelines he was given. For example, for a long while youtube banned every video talking about covid no matter the stance.
- takeda 5y agoYouTube is removing things for liability reasons, that's it, because if some event that caused people to die or have long lasting health effects, would be linked to them and they would be proven they knew and did nothing they would be open to lawsuits.
- mmargerum 5y agoThe spike protein is the disease
- deleted 5y ago[deleted]
- nabla9 5y agoIf person is suffering from ischemia/hypoxia due to covid, that could be the way to lose gray matter.
- subroutine 5y agoLooking at the scatter plot [1] from their most statistically significant finding (parahippocampal gray matter change), the effect size is tiny, and the variance is large. Nearly half the case participants had more gray matter after getting covid. [1] https://i.ibb.co/5YcxJHH/EDB20654-900-A-427-C-8063-B5-FA667-A0-D79.jpg https://i.ibb.co/5YcxJHH/EDB20654-900-A-427-C-8063-B5-FA667-...
- yjftsjthsd-h 5y agoSo the preferred headline here would have been "covid can increase brain matter":) Although of course with that kind of stats I'd prefer no headline at all.
- username90 5y agoStress reduces brain volume in similar areas, this effect could just be that people got extremely stressed out from having caught the pandemic virus. I'd like to see these studies take stress into account before I believe that covid hurts your brain. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4677120/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4677120/
- turnerc 5y agoNote there is a corrected version of this paper: https://www.medrxiv.org/content/10.1101/2021.06.11.21258690v2 https://www.medrxiv.org/content/10.1101/2021.06.11.21258690v... Which includes 3 diabetes patients for comparison of hospitalised and non-hospitalised in Table figure 3.
- tekstar 5y agoI'm pretty sure we had covid in March 2020, and my wife has since then been extremely tired - like needs a 2 hour nap every afternoon and in bed by 8pm - and brain foggy. She's had concussions in the past, so I haven't been sure when one brain fog ended and the other fog started, but I do wonder if it's post-covid related. I just don't know what to do about it though. Doctors are finding nothing.